Fundraising Fox

Biotech Series C Investors & VC Firms

600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.

Recharge Thematic Ventures Management Llc
New YorkSeed–Late Stage
9 people
Oita Venture Capital
OitaPre-Seed–Growth
1 person
QC·VENTURES
ViennaSeed–Late Stage$216K – $4.3M
7 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
9 people
Eurazeo
ParisSeries A–Late Stage
12 people
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
8 people
Kama Flow
MoscowSeed–Late Stage
2 people
Cycad Group LLC
Santa BarbaraSeed–Late Stage
4 people
Averin Capital
New YorkSeed–Growth
9 people
Cure Kids Ventures
AucklandSeed–Growth
6 people
HongShan Capital Group
Hong KongPre-Seed–Late Stage
Kinnevik
StockholmSeed–Late Stage
Pivotal bioVenture Partners
San FranciscoSeed–Late Stage
12 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
8 people
Angelini Ventures
RomeSeed–Growth
4 people
GLOCAL Latam
RosarioPre-Seed–Growth$500K
7 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
Ming capital
ShenzhenSeed–Late Stage
6 people
Ontario Centre of Innovation programs
TorontoPre-Seed–Growth
3 people
Black Diamond Ventures
GlendalePre-Seed–Late Stage$2M – $10M
8 people
CapMan
HelsinkiSeries A–Late Stage$2.2M – $64.8M
4 people
Checkmate Capital Group LLC
PasadenaSeed–Late Stage
7 people
Blume Ventures
MumbaiSeed–Late Stage$650K – $36M
12 people
Commodore Capital
New YorkSeries C–Late Stage
12 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.